May 12, 2010 · Leave a comment
May 12, 2010 (CHAPEL HILL, NC) Thought Leader Select, a North Carolina firm dedicated to delivering the most accurate and effective key opinion leader (KOL) profiling research for the biopharmaceutical industry, announces the commencement of a significant new research assessment for a top-10 global pharmaceutical company.
The pharmaceutical company chose Thought Leader Select to identify and profile 50 key opinion leaders to collaborate with the company in the development and launch of new medicines for children. The scope of the research includes the identification and profiling of pediatricians, primary care physicians, internal medicine specialists, emergency doctors, and other key specialists in pediatrics. Thought Leader Select’s deep-profiling methodology will match key opinion leaders with the appropriate development areas for the company, based on the respective KOLs’ skills, experiences, and interests.
In addition to the KOL identification and profiling research, the company has contracted Thought Leader Select to develop a set of activities to assist with the advancement of new and better medicines for children. This collaborative effort will result in a better working relationship between the pharmaceutical company and thought leaders in pediatrics.
“We are grateful for the opportunity to assist our client in improving their relationship with important thought leaders as they develop better medicines to address childhood illnesses,” stated Paul Meade, Thought Leader Select’s president. “Physicians who care for children are also ... read more »